DalsnaFinance › IPOs › Candel Therapeutics Inc › IPO
Candel Therapeutics, Inc. completed its initial public offering on NASDAQ on July 27, 2021, pricing at $8.00 a share.
| Ticker | CADL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 27, 2021 |
| Offering price | $8.00 |
| Shares offered | 9,000,000 |
| Total raised | $72M |
Candel Therapeutics, Inc. sold 9,000,000 shares at $8.00 each on NASDAQ. Multiplied out, that is $72 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $72 million total recorded for the deal.
Candel Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Candel Therapeutics, Inc.. This page is general information, not investment advice.